CLB — Core Laboratories N.V.

Core Laboratories (CLB) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Q4 Revenue: $138.3 million, up 3% sequentially and 7% year-over-year.
• Full Year Revenue: $526.5 million, a slight increase from 2024.
• Net Income (ex items) Q4: $9.7 million, down 5% sequentially and 7% year-over-year; GAAP net income was $7.1 million.
• Earnings Per Share (EPS) (ex items): $0.21 for Q4, down from $0.22 in Q3 and Q4 2024; full year EPS (ex items) was $0.75, down 14% from 2024.
• Operating Margins: Reservoir Description at 14% (up 60 bps sequentially), Production Enhancement at 7% (down from 11% in Q3).
• Free Cash Flow: $5.1 million for Q4; full year capital expenditures (CapEx) were $11.2 million (excluding UK facility rebuild).

2. Strategic Updates and Business Highlights:

• Core Lab continues to focus on technology investments to solve client problems and capitalize on geographic opportunities.
• Strong international demand for proprietary technologies helped offset a soft U.S. land market.
• The company returned $5.7 million to shareholders through stock buybacks in Q4, marking the fifth consecutive quarter of buybacks.
• Significant projects in South America and advancements in carbon capture initiatives were highlighted, showcasing Core's expanding capabilities.

3. Forward Guidance and Outlook:

• For Q1 2026, revenue is projected between $124 million and $130 million, with operating income of $9.7 million to $12.2 million.
• Reservoir Description revenue expected to range from $82 million to $86 million; Production Enhancement from $42 million to $44 million.
• EPS for Q1 2026 is anticipated to be between $0.11 and $0.15.
• Despite seasonal declines expected in Q1, long-term demand for oilfield services remains strong, driven by global crude oil demand growth forecasts.

4. Bad News, Challenges, or Points of Concern:

• Geopolitical tensions and sanctions negatively impacted demand for laboratory services tied to crude oil trade.
• Declining U.S. onshore completion activity and associated product sales, particularly in the context of fluctuating commodity prices.
• Increased costs due to tariffs on imported raw materials, affecting margins, particularly in the Production Enhancement segment.
• Weather disruptions in early January 2026 impacted operations and client activities, creating additional revenue headwinds.

5. Notable Q&A Insights:

• Management discussed potential opportunities in Venezuela, emphasizing a cautious approach due to the challenging environment but noted legacy data could be monetized.
• The Middle East remains a strong market, with ongoing projects and expansions in lab capabilities.
• There is a trend towards increased exploration activity in international markets, particularly in Africa and Brazil, which could lead to sustained demand for Core's services.
• Questions regarding future cash flows highlighted a balanced approach between debt repayment and share buybacks, with management indicating a preference for opportunistic buybacks in the current market.

Overall, Core Laboratories demonstrated resilience in its financial performance amid external challenges, maintaining a focus on strategic growth and shareholder returns while navigating a complex market landscape.